University of Kentucky researchers were recently awarded a prestigious Centers of Biomedical Research Excellence (COBRE) ...

University of Kentucky researchers have been awarded a prestigious Centers of Biomedical Research Excellence (COBRE) grant that will significantly bolster diabetes prevention research.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teplizumab (Tzield, Aventis Pharma Limited) as the UK’s first immunotherapy for type 1 diabetes (T1D). The drug is licensed ...

An estimated 350 million people in the world have diabetes, according to a major new international study published Online First by The Lancet. The study shows that diabetes prevalence has risen (in ...

A budget-friendly 100-year-old medication could enhance life for people with type 1 diabetes, new research suggests. A ...

Older adults with the most irregular sleep durations demonstrated a 34% higher risk of developing type 2 diabetes compared with those with the most regular sleep. In the study led by Brigham and Women ...

The five-year SURMOUNT-REAL UK trial, part of a collaboration signed last year between Lilly and the UK government, will ...

A DIABETES team has won an award for transforming care for young adults. The Young Adults Diabetes Team at St Helens Hospital, part of Mersey and West Lancashire Teaching Hospitals NHS Trust, was ...

Young people’s consumption of foods high in sodium, sugar, and unhealthy fats is increasing their risk of diabetes, a study ...